seed
Stage
1
Investors
About
MexBrain is a clinical-stage company developing a novel superchelating polymer medical device, MEX-CD1, designed to extract toxic metals from the blood during dialysis, targeting conditions such as Wilson's Disease and Acute Kidney Injury.
Explore MEXBRAIN's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.